This, in turn, promotes lipid droplet–mitochondria contact in HNSCC cells through PLIN2–CPT1A binding, counteracting cisplatin-induced ROS elevation and contributing to chemoresistance. Here, CPT1A is linked to head and neck squamous cell carcinoma.